Skip to content
Screener

Eton Pharmaceuticals, Inc. ETON Prepaid & Other Current

Prepaid & Other Current at other companies

HRO
HarrowHROW
$9.95M-13.9%
XER
Xeris Biopharma Holdings, Inc.XERS
$13.98M+134%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$31.94M+111%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$4.79M+10.2%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$25.75M+10.7%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$395K+9,775%

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$1.22B+167%
Enterprise value$1.23B+167%
P/S14.1×+6.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:17 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001437749-26-017064
Line itemMarch 31, 2026December 31, 2025
Cash and cash equivalents$19,661$25,942
Accounts receivable, net13,40811,757
Inventories, net14,46715,419
Prepaid expenses and other current assets5,7097,463
Total current assets53,24560,581
Property and equipment, net372326
Intangible assets, net43,73830,878
Operating lease right-of-use assets, net301310

Document

FAQ

What is Eton Pharmaceuticals, Inc.'s prepaid & other current?
Eton Pharmaceuticals, Inc. (ETON) reported prepaid & other current of $5.71M in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s prepaid & other current changed year-over-year?
Eton Pharmaceuticals, Inc.'s prepaid & other current increased by 126.6% year-over-year, from $2.52M to $5.71M.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s prepaid & other current has grown at a 28.7% compound annual growth rate (CAGR), from $2.12M to $7.46M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Eton Pharmaceuticals, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude